Global Fibromyalgia Market and Competitive Landscape – 2017

1. Fibromyalgia: Disease Overview

1.1. Fibromyalgia Symptoms

1.2. Fibromyalgia Etiology

1.3. Fibromyalgia Diagnosis

1.4. Fibromyalgia Treatment Options

2. Fibromyalgia Pipeline Insights

2.1. Fibromyalgia Phase 3 Clinical Trials

2.2. Fibromyalgia Phase 2 Clinical Trials

2.3. Fibromyalgia Phase 1 Clinical Trials

3. Fibromyalgia Epidemiology Analysis

4. US Fibromyalgia Market Insights

4.1. Marketed Products for Fibromyalgia in US

4.2. US Fibromyalgia Market Size & Forecast

4.3. US Fibromyalgia Product Sales Forecast

4.4. US Fibromyalgia Market Share Analysis

5. Germany Fibromyalgia Market Insights

5.1. Marketed Products for Fibromyalgia in Germany

5.2. Germany Fibromyalgia Market Size & Forecast

5.3. Germany Fibromyalgia Product Sales Forecast

5.4. Germany Fibromyalgia Market Share Analysis

6. France Fibromyalgia Market Insights

6.1. Marketed Products for Fibromyalgia in France

6.2. France Fibromyalgia Market Size & Forecast

6.3. France Fibromyalgia Product Sales Forecast

6.4. France Fibromyalgia Market Share Analysis

7. Italy Fibromyalgia Market Insights

7.1. Marketed Products for Fibromyalgia in Italy

7.2. Italy Fibromyalgia Market Size & Forecast

7.3. Italy Fibromyalgia Product Sales Forecast

7.4. Italy Fibromyalgia Market Share Analysis

8. Spain Fibromyalgia Market Insights

8.1. Marketed Products for Fibromyalgia in Spain

8.2. Spain Fibromyalgia Market Size & Forecast

8.3. Spain Fibromyalgia Product Sales Forecast

8.4. Spain Fibromyalgia Market Share Analysis

9. UK Fibromyalgia Market Insights

9.1. Marketed Products for Fibromyalgia in UK

9.2. UK Fibromyalgia Market Size & Forecast

9.3. UK Fibromyalgia Product Sales Forecast

9.4. UK Fibromyalgia Market Share Analysis

10. Europe Fibromyalgia Market Insights

10.1. Europe Fibromyalgia Market Size & Forecast

10.2. Europe Fibromyalgia Product Sales Forecast

10.3. Europe Fibromyalgia Market Share Analysis

11. Japan Fibromyalgia Market Insights

11.1. Marketed Products for Fibromyalgia in Japan

11.2. Japan Fibromyalgia Market Size & Forecast

11.3. Japan Fibromyalgia Product Sales Forecast

11.4. Japan Fibromyalgia Market Share Analysis

12. Global Fibromyalgia Market Insights

12.1. Global Fibromyalgia Market Size & Forecast

12.2. Global Fibromyalgia Product Sales Forecast

12.3. Global Fibromyalgia Market Share Analysis

13. Research Methodology

LIST OF TABLES

Table 1: Fibromyalgia Phase 3 Clinical Trials, Global, 2017

Table 2: Fibromyalgia Phase 2 Clinical Trials, Global, 2017

Table 3: Fibromyalgia Phase 1 Clinical Trials, Global, 2017

Table 4: Fibromyalgia Prevalence by G7 Countries, 2012 - 2021

Table 5: Marketed Products for Fibromyalgia in US, 2017

Table 6: US Fibromyalgia Market Size & Forecast ($mn), 2012 - 2021

Table 7: US Fibromyalgia Product Sales ($mn), 2012 - 2021

Table 8: US Fibromyalgia Market Trends, 2012 - 2021

Table 9: Marketed Products for Fibromyalgia in Germany, 2017

Table 10: Germany Fibromyalgia Market Size & Forecast ($mn), 2012 - 2021

Table 11: Germany Fibromyalgia Product Sales ($mn), 2012 - 2021

Table 12: Germany Fibromyalgia Market Trends, 2012 - 2021

Table 13: Marketed Products for Fibromyalgia in France, 2017

Table 14: France Fibromyalgia Market Size & Forecast ($mn), 2012 - 2021

Table 15: France Fibromyalgia Product Sales ($mn), 2012 - 2021

Table 16: France Fibromyalgia Market Trends, 2012 - 2021

Table 17: Marketed Products for Fibromyalgia in Italy, 2017

Table 18: Italy Fibromyalgia Market Size & Forecast ($mn), 2012 - 2021

Table 19: Italy Fibromyalgia Product Sales ($mn), 2012 - 2021

Table 20: Italy Fibromyalgia Market Trends, 2012 - 2021

Table 21: Marketed Products for Fibromyalgia in Spain, 2017

Table 22: Spain Fibromyalgia Market Size & Forecast ($mn), 2012 - 2021

Table 23: Spain Fibromyalgia Product Sales ($mn), 2012 - 2021

Table 24: Spain Fibromyalgia Market Trends, 2012 - 2021

Table 25: Marketed Products for Fibromyalgia in UK, 2017

Table 26: UK Fibromyalgia Market Size & Forecast ($mn), 2012 - 2021

Table 27: UK Fibromyalgia Product Sales ($mn), 2012 - 2021

Table 28: UK Fibromyalgia Market Trends, 2012 - 2021

Table 29: Europe Fibromyalgia Market Size & Forecast ($mn), 2012 - 2021

Table 30: Europe Fibromyalgia Product Sales ($mn), 2012 - 2021

Table 31: Marketed Products for Fibromyalgia in Japan, 2017

Table 32: Japan Fibromyalgia Market Size & Forecast ($mn), 2012 - 2021

Table 33: Japan Fibromyalgia Product Sales ($mn), 2012 - 2021

Table 34: Japan Fibromyalgia Market Trends, 2012 - 2021

Table 35: Global Fibromyalgia Market Size & Forecast ($mn), 2012 - 2021

Table 36: Global Fibromyalgia Product Sales ($mn), 2012 - 2021

LIST OF FIGURES

Figure 1: Fibromyalgia Pipeline by Phase (%), Global, 2017

Figure 2: Fibromyalgia Prevalence by G7 Countries, 2012 - 2021

Figure 3: US Fibromyalgia Market Size ($mn), 2012 - 2021

Figure 4: US Fibromyalgia Product Sales ($mn), 2012 - 2021

Figure 5: US Fibromyalgia Market Share by Products (%), 2016

Figure 6: US Fibromyalgia Market - Future Market Share (%), 2021

Figure 7: Germany Fibromyalgia Market Size ($mn), 2012 - 2021

Figure 8: Germany Fibromyalgia Product Sales ($mn), 2012 - 2021

Figure 9: Germany Fibromyalgia Market Share by Products (%), 2016

Figure 10: Germany Fibromyalgia Market - Future Market Share (%), 2021

Figure 11: France Fibromyalgia Market Size ($mn), 2012 - 2021

Figure 12: France Fibromyalgia Product Sales ($mn), 2012 - 2021

Figure 13: France Fibromyalgia Market Share by Products (%), 2016

Figure 14: France Fibromyalgia Market - Future Market Share (%), 2021

Figure 15: Italy Fibromyalgia Market Size ($mn), 2012 - 2021

Figure 16: Italy Fibromyalgia Product Sales ($mn), 2012 - 2021

Figure 17: Italy Fibromyalgia Market Share by Products (%), 2016

Figure 18: Italy Fibromyalgia Market - Future Market Share (%), 2021

Figure 19: Spain Fibromyalgia Market Size ($mn), 2012 - 2021

Figure 20: Spain Fibromyalgia Product Sales ($mn), 2012 - 2021

Figure 21: Spain Fibromyalgia Market Share by Products (%), 2016

Figure 22: Spain Fibromyalgia Market - Future Market Share (%), 2021

Figure 23: UK Fibromyalgia Market Size ($mn), 2012 - 2021

Figure 24: UK Fibromyalgia Product Sales ($mn), 2012 - 2021

Figure 25: UK Fibromyalgia Market Share by Products (%), 2016

Figure 26: UK Fibromyalgia Market - Future Market Share (%), 2021

Figure 27: Europe Fibromyalgia Market Size ($mn), 2012 - 2021

Figure 28: Europe Fibromyalgia Product Sales ($mn), 2012 - 2021

Figure 29: Europe Fibromyalgia Market Share by Products (%), 2016

Figure 30: Europe Fibromyalgia Market - Future Market Share (%), 2021

Figure 31: Japan Fibromyalgia Market Size ($mn), 2012 - 2021

Figure 32: Japan Fibromyalgia Product Sales ($mn), 2012 - 2021

Figure 33: Japan Fibromyalgia Market Share by Products (%), 2016

Figure 34: Japan Fibromyalgia Market - Future Market Share (%), 2021

Figure 35: Global Fibromyalgia Market Size ($mn), 2012 - 2021

Figure 36: Global Fibromyalgia Product Sales ($mn), 2012 - 2021

Figure 37: Global Fibromyalgia Market Share by Products (%), 2016

Figure 38: Global Fibromyalgia Market - Future Market Share (%), 2021

Global Fibromyalgia Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Fibromyalgia Market and Competitive Landscape – 2017, provides comprehensive insights into Fibromyalgia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Fibromyalgia market size and drug sales. This research also provides insights into Fibromyalgia epidemiology and late stage pipeline.
The report is classified into twelve sections – Fibromyalgia overview with definitions, symptoms, etiology, diagnosis, treatment options; Fibromyalgia pipeline insights covering late stage clinical trials pipeline; Fibromyalgia prevalence trends by countries; Fibromyalgia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

• Fibromyalgia pipeline: Find out the drugs in clinical trials for Fibromyalgia by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
• Fibromyalgia epidemiology: Find out the prevalence of Fibromyalgia by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
• Fibromyalgia products: Identify key products marketed and prescribed for Fibromyalgia by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
• Fibromyalgia market size: Find out the market size for Fibromyalgia drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
• Fibromyalgia drug sales: Find out the sales of Fibromyalgia drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
• Fibromyalgia drugs sales forecast: Sales forecast for Fibromyalgia drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
• Fibromyalgia market share analysis: Find out the market shares of Fibromyalgia drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research: The research helps executives to

• Evaluate commercial market opportunities for Fibromyalgia drugs
• Synthesize insights for business development & licensing
• Track market size, competitor drug sales, market shares in Fibromyalgia market
• Develop in-depth knowledge of competition and markets
• Analyze sales data to update your brand planning trackers
• Develop tactics and strategies to take advantage of opportunities in the market
• Track market trends and analyze key events in Fibromyalgia market
• Develop forecast models, healthcare frameworks, or economic models
• Answer key business questions; supports decision making in R&D to long term marketing strategies